中国胰腺癌多学科综合治疗(MDT)模式专家共识(2020版)
该共识由中国专家基于胰腺癌诊治现状修订,指出胰腺癌5年总生存率仅7.2%,短期内难以突破,强调通过规范化MDT优化现有诊疗方法以改善疗效。共识详细论述MDT的意义、任务、条件、流程、注意事项、相关研究及多中心与eMDT模式探索,旨在推动我国胰腺癌MDT规范化开展,并可供其他肿瘤借鉴。
要点
- 胰腺癌5年总生存率仅7.2%,现有治疗短期难突破,规范化MDT是改善疗效的迫切途径。
- 共识详述MDT的意义、任务、客观条件、工作流程及注意事项,推动规范化开展。
- 探索多中心MDT和eMDT模式,共识不仅适用于胰腺癌,也可供其他肿瘤借鉴。
核心结论
- 通过规范化MDT优化组合现有诊疗方法制定个性化方案,是短期内改善胰腺癌疗效的迫切解决方案。
- 本共识旨在推动我国胰腺癌MDT规范化开展,并可為其他肿瘤提供借鉴。
研究设计与样本
- 本共识为专家共识,由国内众多知名专家在第1版基础上,参照国内外成功诊治经验并结合中国国情,经反复讨论修订而成。
主要发现
- 胰腺癌病因未明、预防困难,辅助检测灵敏度和特异度低,早诊是世界性难题。
- 现有治疗手段疗效不满意且短期内难以突破,总5年生存率仅7.2%。
关键数值与推荐
- 共识推荐通过规范化MDT优化组合现有诊疗方法,制定个性化治疗方案以改善疗效。
- 共识详细论述了MDT的意义和宗旨、主要任务、开展的必要客观条件、工作流程及注意事项。
- 共识涉及相关临床和基础研究、多中心MDT模式探索及eMDT模式探索。
临床怎么用
- 临床应按照共识推动胰腺癌MDT的规范化开展,优化现有诊疗方法的组合。
- 开展MDT需满足共识规定的必要客观条件,遵循工作流程和注意事项。
- 可探索多中心MDT和eMDT模式,并加强人才培养和梯队建设。
局限性
- 基础和早期诊断技术研究时间长、费用高,短期内难以见效。
- 本共识为专家共识,并非基于系统评价或随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The current situation of pancreatic cancer is that the etiology is not clear and prevention is difficult. The sensitivity and specificity of the auxiliary detection method are low, and early diagnosis is a worldwide problem. The efficacy of existing treatment method is not satisfied and is difficult to break through in a short time. The 5-year overall survival rate is only 7.2%. In face of the current situation of pancreatic cancer, the key solution is to strengthen basic research, explore its etiology and pathogenesis, prevent carcinogenesis and development. Developments of the efficacy of peripheral blood and urine detection technology, imaging diagnosis technology are the critical manners to improve the early diagnosis rate. However, the research on basic and early diagnosis techniques takes a long time and costs a lot, which makes it difficult to achieve result in a short time. Therefore, the problem to be solved urgently is to develop a personalized treatment plan through standardized multi-disciplinary treatment (MDT), optimized combination of existing diagnosis and treatment methods, which may achieve the purpose of improving efficacy. This expert consensus is developed from the first edition, which is based on the diagnosis and treatment status of pancreatic cancer and the dilemma that is difficult to break through in a short time, with reference to the successful diagnosis and treatment experience at home and abroad, combined with the national condition of our country, repeated deliberation, discussion and revision by many domestic well-known experts. This consensus discusses the meaning and purpose, the main tasks, the necessary objective conditions for carrying out, workflows, precautions, relevant clinical and basic research of MDT, explorations of multi-center MDT mode and internet MDT (eMDT) mode in detail. Through the formulation and publication of this consensus, we hope that it can promote the development of standardized pancreatic cancer MDT and improve the therapeutic efficacy of pancreatic cancer in China, summarize successful experience and promote international exchanges, strengthen personnel training and echelon construction, formulate relevant policy and promote the development of MDT in the whole country. This is an expert consensus on the MDT model developed in China, which is not only applied to pancreatic cancer, but also can be used as a reference for other tumors. 胰腺癌的病因尚未完全明确,预防便尤为困难。辅助检测手段的灵敏度和特异度低,早诊是世界性难题,现有的治疗手段疗效不满意,且短期内难以突破,总的5年生存率仅7.2%。面对胰腺癌的现状,要加强基础研究、探究其病因和发病机制,去除病因、切断发生发展路径。研发高灵敏度、高特异度的外周血和尿液等检测技术以及影像诊断技术以提高早期诊断率和疗效,但基础和早期诊断技术的研究时间长、费用高,短期内难以见效。因此,急需解决的问题是通过规范的多学科综合治疗(MDT)、优化组合现有的诊疗方法,制定个性化的治疗方案,达到改善疗效的目的。本共识是在第1版的基础上,基于胰腺癌的诊治现状且短期内难以突破的窘境,参照国际、国内成功的诊治经验,结合中国国情、由国内业界众多知名专家参与,经反复推敲、讨论、几易其稿成文。本共识就MDT的意义和宗旨、主要任务、开展的必要客观条件、工作流程、注意事项、相关临床和基础研究、多中心MDT模式探索、eMDT模式探索等方面进行了详细论述,希望能为推动我国胰腺癌MDT的规范化开展、改善胰腺癌的疗效、总结成功经验、促进国际交流、加强人才培养和梯队建设有所裨益;为国家制定相关政策、推动全国MDT的开展有所帮助。本共识不仅仅适用于胰腺癌,也可供其他肿瘤借鉴。.
引用
- [Expert consensus on the MDT model of pancreatic cancer in China (2020 Edition)]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32842438. doi:10.3760/cma.j.cn112152-20200310-00192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。